Bruce Porterfield, MD
Medical Oncology · Panama City, FLNPI 1962451377
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,167 of the $2,476 with a category attached, or 87.5%. It is spread thinly across 38 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for medical oncology clinicians in FL, where the typical reported total is $8,890.
Across 122 payments — averaging $20.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$306
- Incyte Corporation$237
- E.r. Squibb & Sons, L.L.C.$196
- Pfizer$184
- Bristol Myers Squibb$161
- AbbVie$118
- plus $1K from 32 others
Across 139 payments — averaging $1082.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$97K
- E.r. Squibb & Sons, L.L.C.$29K
- EMD Serono, Inc.$24K
What the payments were for
- Food & beverage$2,16788%
- Education$30912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 11 | $306 |
| Incyte Corporation | 4 | $237 |
| E.r. Squibb & Sons, L.L.C. | 10 | $196 |
| Pfizer | 18 | $184 |
| Bristol Myers Squibb | 6 | $161 |
| AbbVie | 5 | $118 |
| Novartis | 5 | $109 |
| Astellas Pharma US Inc | 5 | $107 |
| Array Biopharma Inc | 5 | $87 |
| AstraZeneca | 4 | $71 |
| Merck | 4 | $65 |
| Beone Medicines USA, Inc. | 3 | $65 |
| Beigene USA, Inc. | 3 | $52 |
| GSK | 2 | $45 |
| Amgen | 3 | $45 |
| Lilly USA, LLC | 3 | $45 |
| Verastem, Inc. | 2 | $40 |
| Bayer | 3 | $39 |
| Sanofi | 2 | $37 |
| Boehringer Ingelheim | 2 | $37 |
| EMD Serono, Inc. | 2 | $32 |
| Puma Biotechnology, Inc. | 1 | $30 |
| Gilead(2 entities) | 2 | $30 |
| Mirati Therapeutics, Inc. | 2 | $29 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Coherus Oncology, Inc. | 1 | $26 |
| Seagen Inc. | 2 | $25 |
| Exelixis Inc. | 1 | $24 |
| Secura Bio, Inc. | 1 | $24 |
| Deciphera Pharmaceuticals Inc. | 1 | $24 |
| AVEO Pharmaceuticals, Inc. | 1 | $22 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DARZALEX$110
How this compares
$2,476 in reported general payments places this provider in the 25th percentile of 507 medical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Exemestane | 12 | $727 |
| Anastrozole | 33 | $492 |
| Ondansetron OdtOndansetron | 12 | $187 |
| Acyclovir | 17 | $174 |
| Gabapentin | 13 | $164 |
| Prednisone | 14 | $128 |
| Warfarin Sodium | 13 | $10 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Panama City
- Neil LoveMiami$5.6M
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
- Yasser KhaledOrlando$444K
- Judah FriedmanPalm Beach Gardens$416K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.